Concepedia

Melody Mendenhall

MM

Statistics

Publications

7

Citations

1.5K

H-Index

7

Active since

2000

Affiliations

University of California, Los Angeles(Current)

Melody Mendenhall is an author at University of California, Los Angeles specializing in medicine, radiation oncology, and pharmacotherapy.

Top concepts

Publications per year

2000–2022

7

Publications

7

Rociletinib in <i>EGFR</i>-Mutated Non–Small-Cell Lung Cancer

Lecia V. Sequist, Jean‐Charles Soria, Jonathan W. Goldman et al. · New England Journal of Medicine · 2015 · 660 citations · Full text

A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLC

Aaron Lisberg, Amy L. Cummings, Jonathan W. Goldman et al. · Journal of Thoracic Oncology · 2018 · 577 citations · Full text

, , +7

Treatment-Related Adverse Events Predict Improved Clinical Outcome in NSCLC Patients on KEYNOTE-001 at a Single Center

Aaron Lisberg, D. Andrew Tucker, Jonathan W. Goldman et al. · Cancer Immunology Research · 2018 · 102 citations

Granulocyte macrophage colony-stimulating factor and interleukin 4 enhance the number and antigen-presenting activity of circulating CD14+ and CD83+ cells in cancer patients.

Michael D. Roth, Barbara J. Gitlitz, Sylvia M. Kiertscher et al. · PubMed · 2000 · 64 citations

, , +17

Diverse cutaneous adverse eruptions caused by anti-programmed cell death-1 (PD-1) and anti-programmed cell death ligand-1 (PD-L1) immunotherapies: clinical features and management

John Shen, Jason Y.H. Chang, Melody Mendenhall et al. · Therapeutic Advances in Medical Oncology · 2018 · 37 citations · Full text

1–5 of 7